84 FR 99 pgs. 23581-23582 - Importer of Controlled Substances Registration
Type: NOTICEVolume: 84Number: 99Pages: 23581 - 23582
Pages: 23581, 23582Docket number: [Docket No. DEA-392]
FR document: [FR Doc. 2019-10669 Filed 5-21-19; 8:45 am]
Agency: Justice Department
Sub Agency: Drug Enforcement Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Registration
ACTION:
Notice of registration.
SUMMARY:
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and schedule II controlled substances.
SUPPLEMENTARY INFORMATION:
The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for a hearing were submitted for these notices.
[top]
Company | FR docket | Published |
---|---|---|
Meridian Medical Technologies | 84 FR 7129 | March 1, 2019. |
Organic Standards Solutions International, LLC | 84 FR 13958 | April 8, 2019. |
SpecGx LLC | 84 FR 13954 | April 8, 2019. |
The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I and II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I and schedule II controlled substances to the above listed companies.
Dated: May 7, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-10669 Filed 5-21-19; 8:45 am]
BILLING CODE 4410-09-P